Thomas W. Dubensky

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Berkeley, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Stephen Brady, Attorney-in-Fact for Thomas W. Dubensky
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Thomas W. Dubensky

Form 4 holding President, Director

Tempest Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
102,700
Estimated value
Report date
03 Jan 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

HTG MOLECULAR DIAGNOSTICS, INC

Security class
Stock Option (right to buy)
Shares / value
8,000
Estimated value
Report date
18 Aug 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Thomas W. Dubensky

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .